5 articles
Living with Crohn’s disease can feel like a full-time job. You are often managing flare-ups, navigating restrictive diets, and balancing the side effects of biologics or steroids. While traditional medicine is effective at targeting clinical remission and healing the gut lining, many patients experience a 'symptomatic gap.' Your lab results might look normal, but you may still battle debilitating pain, urgency, and exhaustion.
The Endocannabinoid System (ECS) acts as a primary regulator for the bidirectional communication of the gut-brain axis. Moving beyond recreational cannabis use, technical application for digestive health requires a shift toward targeted dosing and precise delivery vectors. By modulating Endocannabinoid Tone, individuals may support the prevention of gut stasis and the mitigation of inflammatory responses within the enteric nervous system.
Your gut functions as your second engine. High-performance training requires efficient nutrient absorption and systemic balance, yet intense physical exertion often triggers Exercise-Induced Gastrointestinal Syndrome (EIGS). This condition—manifesting as nausea, reflux, and increased intestinal permeability—is a common performance obstacle.
High-performance training demands an 'iron stomach.' Yet, for endurance runners, triathletes, and weightlifters, the gut is often the first system to fail under intense load. Exercise-Induced Gastrointestinal Syndrome (EIGS) impacts up to a significant portion of endurance athletes (estimates vary widely across sports and intensity levels), manifesting as cramps, 'runner’s trots,' and systemic inflammation that may sideline training for days.
The Endocannabinoid System (ECS) serves as the primary regulatory framework for the enteric nervous system (ENS). Current clinical data suggests the ECS acts as a biological thermostat, helping to manage the balance between the brain and the digestive tract. The market is shifting from general wellness claims toward precision gastroenterology, driven by an understanding of receptor density, enzymatic degradation, and retrograde signaling.